#Hematology/
#Cancer diagnosis and treatment represents a significant expenditure in
developed #healthcare systems. #Cancer screening is performed through
routine tests such as complete blood counts #(CBCs), #differentials, and
#protein #markers. However, the global #oncology #diagnostics market is
quickly evolving past established #markers and companion #diagnostics
in the United States, Europe and Japan. #Targeted #cancer #therapies are
finding significant demand in emerging middle-income countries such as
China and new technologies such as liquid #biopsies, next-generation
sequencing #(NGS) and novel hybridization #assays are being developed
for #cancer #detection and #diagnosis.
To tell something more about this track, submit your abstracts here:
To get to know more about our Congress, Visit:
No comments:
Post a Comment